SUMMARY Ethane-l-hydroxy-1,1-diphosphonate (EHDP) inhibits bone mineral growth. This study was performed to test the hypothesis that EHDP would interfere with the process of calcium uptake and deposition in evolving myocardial infarction and thereby influence other parameters, including technetium-99m pyrophosphate (Tc-99m PYP) uptake and scintigraphic visualization of the infarcts. 
PHOSPHATES (general chemical formula [P-O-P]n)
and phosphonates (general chemical formula [P-C-P]) have an affinity for various calcific species associated with biologic calcification, including hydroxyapatite.''5 Substitution of a carbon for oxygen renders the phosphonates more stable than the polyphosphates in vivo by decreasing the susceptibility of the compounds to enzymatic degradation.'-" Phosphonates, including ethane-l-hydroxy-l,l-diphosphonate (EHDP), inhibit skeletal and soft tissue calcification.'-5 Polyphosphates, including pyrophosphate (PYP), and phosphonates also have an affinity for acutely necrotic muscle; radiopharmaceuticals of these agents tagged with technetium-99m (99mTc) accumulate in acute myocardial infarcts and necrotic skeletal muscle.6-" This uptake of the radiopharmaceuticals is at least in part related to an affinity for calcific deposits that develop in areas of damaged muscle with significant residual perfusion. 6 'l Several studies indicate that alterations of calcium homeostasis, including altered calcium flux and calcium accumulation, can induce irreversible myocardial injury.12 -1 Drugs that interfere with transmembrane calcium movements may reduce the extent of myocardial damage.12-19 The present study was undertaken to evaluate the effect of continuous infusion of EHDP on the process of calcium uptake and deposition during evolving experimental myocardial infarction and to evaluate the effect of altered calcium deposition on other parameters, including subsequent uptake of 99mTc-PYP and scintigraphic visualization of the infarcts.
Materials and Methods

Protocol
Purebred beagles, 9-12 kg, were tranquilized with an i.v. injection of 0.5 ml xylazine (20 mg/ml) (Rhompun) and 1 ml ketamine (100 mg/ml) (Vetalar) and anesthetized with an i.v. injection of 1.5-4.5 ml of sodium thiamylal (5 g/ 100 ml) (Surital). Each dog was placed on a Harvard respirator and ventilated with room air. Cannulas were inserted into a carotid artery and the right and left jugular veins. An infusion was begun through one of the venous catheters of either normal saline (12 dogs) or EHDP (12 dogs). The study was performed such that control dogs were interspersed with EHDP dogs. The infusion was begun with a Harvard infusion pump and, after the surgical procedure was completed, subsequently maintained until the end of the study with a small infusion pump EFFECT OF EHDP ON CALCIUM AND 9*mTc-PYP/Buja et al.
(Cormed Inc.) placed in a backpack and strapped to the animals. Solutions of "4C-labeled EHDP were used at concentrations calculated to maintain serum levels of 10-15 ,ug/ml. A 0.7% 14C EHDP solution was used with the Harvard infusion pump (20-ml syringe, setting 7) and a 2% "C EHDP solution with the backpack pump. Venous blood samples were collected from a jugular venous catheter at 1, 3 and 24 hours after the start of the infusion. Serum levels of 14C EHDP were assayed by direct liquid scintillation counting in Triton X-100.
After a thoracotomy and pericardiotomy, a left atrial catheter was inserted. Radioactive microspheres (7-10 ,u) were injected through the left atrial catheter and arterial blood samples were collected for subsequent measurement of myocardial blood flow. [20] [21] [22] The radioactive microsphere blood flow measurements were made with a standard dose (approximately 1,000,000), which has not been associated with significant hemodynamic alterations or microvascular obstruction.20 22 Thirty minutes after the infusion of saline or EHDP was begun, the proximal left anterior descending coronary artery (LAD) just distal to the origin of the first major septal and lateral branches was ligated. Fifteen minutes after LAD ligation, a second dose of microspheres was injected. The thoracotomy was closed, and a vest with the backpack infusion pump was secured to the dog. The dog was allowed to recover from anesthesia.
The next day, the dog was again tranquilized and anesthetized as described above. An i.v. injection of 3-4 mCi of Tc-99m PYP was given 22 hours after LAD occlusion. Two hours later, myocardial scintigrams were obtained in the three standard views (anterior, left anterior oblique and left lateral) using a Searle 37-tube scintillation camera with a 16,000-hole, high-resolution collimator. The camera was set at 140 keV with a 20% window. The Tc-99m PYP myocardial scintigrams were graded according to a standard protocol without knowledge of the treatment group on a scale of 0-4+, with grades 2-4+ considered positive and 0-1+ negative. 8 With the dog anesthetized and on the respirator, the final microsphere injection was performed. The saline or EHDP infusion was discontinued, and the dog was sacrificed 24-25 hours after LAD occlusion with a large dose (more than 60 mg/kg) of i.v. pentobarbital.
The protocol was repeated in an additional seven dogs that received higher doses of 14C EHDP so as to maintain serum levels in the range of 100 ,g/ml.
Tissue Sampling and Processing
The heart was removed and cut into four or five transverse rings. Slice weights, heart weight and left ventricular weights were obtained. Small samples (100-200 mg) were obtained for '9mTc-PYP, 14C EHDP and calcium analyses from the subepicardium and subendocardium of the noninfarcted posterior left ventricle and from the anterior left ventricle, including peripheral and central regions of grossly damaged myocardium. Larger samples (0.5-1 g) were obtained from the same areas for radioactive microsphere measurements. Wet weights on all the samples were obtained.
The ventricular slices were incubated in a solution of 1% triphenyl tetrazolium chloride in phosphate buffer until the noninfarcted tissue stained bright red.28 The slices were then fixed in 10% phosphatebuffered formalin and photographed. Representative tissue blocks were obtained and processed for histologic examination. Photographic prints of the slices were made. Total areas and infarcted areas were traced on the photographic prints and digitized for subsequent calculation of infarct size.
Multiple determinations were made on the 100-200-mg samples. The 99mTc-PYP levels were determined by gamma scintillation counting. After decay of g9mTc, samples were combusted in quartz cups (to collect ash residue for calcium analyses), trapped in a solution of Carbo-Sorb and Permafluorn-I and radioassayed for 14C by liquid scintillation counting. The residual ash was digested in nitric acid and the calcium levels were quantitated by atomic absorption as previously described.7 Cross-contamination from combustion of the 25I, '5Sr and "Sc microspheres was investigated and found to be negligible.
Radioactive microsphere levels in tissue and blood samples were quantitated by gamma spectroscopy several days after sacrifice when ssmTc activity was negligible. A standard computer program was used to correct for cross-contamination from the three isotopes (1211, 85Sr and 4"Sc) and to calculate myocardial blood flows (ml/min/g).
Statistical Analysis
Comparisons of infarct size, blood flow and tissue levels of calcium and "mTc-PYP between groups of dogs were performed with a two-tailed group t test (tables [1] [2] [3] The EHDP dogs showed a significantly higher 9ImTc-PYP level in normal left ventricle compared with the controls (p < 0.05) (table 3). The average infarct levels for "mTc-PYP tended to be lower in the EHDP dogs (n = 6) than in the controls (n = 6) (p-< 0.10). The most significant difference in 99mTc-PYP levels between the two groups was in the central subendocardium (p < 0.01), but the levels tended to be lower in other infarct regions of the EHDP dogs. The mean infarct-to-normal ratio for "mTc-PYP was significantly reduced in the EHDP dogs (p < 0.05). When all infarct samples for 99mTc-PYP were compared between the two groups, the EHDP dogs showed significantly lower "mTc-PYP levels (p < 0.005).
Correlations between myocardial tissue levels of calcium, 99mTc-PYP and '4C EHDP are shown in table 4. All samples with available measurements from normal and infarcted tissue were included in the analyses. There was a good correlation between 99mTc-PYP and calcium levels in the control dogs (r = 0.77). In the EHDP dogs, significant correlations also occurred between calcium and 9ImTc-PYP (r = 0.69) and between calcium and 14C EHDP (r = 0.66) levels. The 99mTc-PYP and "C EHDP levels showed a strong correlation (r = 0.94), indicating that both agents have an affinity for similar tissue-binding sites.
The results of myocardial scintigraphy are summarized in table 5. The myocardial scintigrams were interpreted on a scale of 0-4+8 without knowledge of the treatment received by the dogs. Consistent with the reported sensitivity of approximately 3 g,8 two control dogs with small infarcts of 2.1 and 3.4 g had negative 99mTc-PYP myocardial scintigrams, whereas all five with larger infarcts had positive scintigrams ( fig. 1 ). All EHDP-treated dogs had infarcts of more than 3.5 g. Myocardial scintigrams in the EHDPtreated group, however, generally showed high background activity and decreased visibility of specific infarct uptake. Myocardial scintigrams were read as positive in only four of the seven dogs in the EHDPtreated group (table 5) . The average grade (0-4+) of the wemTc-PYP myocardial scintigrams for infarcts greater than 3.5 g was 2.4 ± 0.2 for the control dogs and 1.1 ± 0.4 for the EHDP-treated dogs (p < 0.05).
Five of the seven high-dose (100 gg/ml) EHDP dogs completed the protocol. All five had gross myocardial infarcts with calcium and 9BmTc-PYP levels similar to those in the saline controls. The highdose EHDP dogs also showed higher levels of 99mTc-PYP and calcium in normal left ventricle than either the control dogs or low-dose EHDP dogs. Discussion When continuously infused at a serum level of 10-15 ,g/ml for 24 hours of coronary occlusion, EHDP did not effect a detectable reduction in infarct size and did not prevent abnormal calcium accumulation in the ischemic region, but did produce a 20% decrease in the calcium content of the infarcted myocardium. These results suggest that the major effect of EHDP on ischemic myocardium is to retard progres- important mechanism in the scintigraphic detection of necrotic myocardium with this agent.6'-EHDP infusion, however, produced an adverse effect on s`mTc-PYP myocardial scintigraphy characterized by a significant decrease (37%) in the uptake of 99mTc-PYP in infarcted myocardium, increased (58%) background activity in normal myocardium, decreased (65%) infarct-to-normal ratio and reduced visualization of infarcts on 9smTc-PYP myocardial scintigrams. Infusion of EHDP at a higher dose (100 gg/ml serum levels) resulted in further deterioration of the infarct-to-normal ratio of somTc-PYP. These effects of EHDP may be explained by partial saturation of 99mTc-PYP binding sites by EHDP and dilution of 99mTc-PYP in the circulating diphosphonate pool at the time of I9mTc-PYP injection.
The clinical implication of these findings is that significant impairment of diagnostic accuracy of 99mTc-PYP myocardial scintigraphy may result from disease states, metabolic alterations or drugs that increase the background level and reduce the infarct-tonormal ratio of ssmTc-PYP. One such condition is chronic renal failure, which may be associated with increased serum phosphate levels, altered pyrophosphate metabolism and, possibly, decreased renal excretion of radiopharmaceuticals.24 25 This study also raises the concern that impaired scintigraphic accuracy may occur in patients receiving various calcium antagonists. This is an important problem because more patients with various ischemic heart disease syndromes are being treated with these agents.26 Each of the calcium antagonists, however, will have to be evaluated with respect to individual effects on 99mTc-PYP myocardial scintigraphy. Finally, our study reinforces the important point that myocardial scintigrams with unacceptably high background and blood pool levels should not be read as positive or negative, but should be considered as uninterpretable and repeated until technically adequate.
